JAZZ · Categories · Upgrades
JAZZ - Analyst upgrades
Jazz Pharmaceuticals plc (JAZZ) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for JAZZ
- Jazz Pharma upgraded by UBS with a new price targetUBS upgraded Jazz Pharma from Neutral to Buy and set a new price target of $307.00
- Jazz Pharma upgraded by UBS with a new price targetUBS upgraded Jazz Pharma from Neutral to Buy and set a new price target of $179.00 from $145.00 previously
- Jazz Pharma upgraded by Wells Fargo with a new price targetWells Fargo upgraded Jazz Pharma from Equal Weight to Overweight and set a new price target of $170.00 from $130.00 previously
- Jazz Pharma upgraded by Morgan Stanley with a new price targetMorgan Stanley upgraded Jazz Pharma from Equal-Weight to Overweight and set a new price target of $175.00 from $140.00 previously
- Jazz Pharma upgraded by Goldman with a new price targetGoldman upgraded Jazz Pharma from Neutral to Buy and set a new price target of $190.00 from $192.00 previously
- Jazz Pharma upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Jazz Pharma from Neutral to Overweight and set a new price target of $175.00 from $150.00 previously